Breast Cancer Targeting Novel microRNA-Nanoparticles for Imaging

被引:2
作者
Natarajan, Arutselvan [1 ]
Venugopal, Senthil K. [1 ]
DeNardo, Sally J. [1 ]
Zern, Mark A. [1 ]
机构
[1] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95816 USA
来源
MULTIMODAL BIOMEDICAL IMAGING IV | 2009年 / 7171卷
关键词
Apoptosis; miRNA; breast cancer; Nanoparticles; Qdot; ICPMS; GOLD NANOPARTICLES; INITIATION; DELIVERY; LET-7;
D O I
10.1117/12.812186
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
MicroRNAs (miRNAs) are one of the most prevalent small (similar to 22 nucleotide) regulatory RNA classes in animals. These miRNAs constitute nearly one percent of genes in the human genome, making miRNA genes one of the more abundant types of regulatory molecules. MiRNAs have been shown to play important roles in cell development, apoptosis, and other fundamental biological processes. MiRNAs exert their influence through complementary base-pairing with specific target mRNAs, leading to degradation or translational repression of the targeted mRNA. We have identified and tested a novel microRNA (miR-491) and demonstrated increased apoptosis in hepatocellular carcinoma cells (HepG2) and in human breast cancer cells (HBT3477) in vitro. We prepared a novel cancer targeting assembly of gold nanoparticles (GNP) with Quantum dots, miR-491, and MAb-ChL6 coupled through streptavidin/biotin for effective transfection, and to induce apoptosis in specific cancer cells for imaging and targeted therapy. The targeting and apoptosis inducing ability was tested by confocal and electron microscopy. The MAb-GNP-miR491-Qdot construct effectively transfected into the HBT3477 cells and induced apoptosis the confirmation of these results would suggest a new class of molecules for the imaging and therapy of breast cancer.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine
    Martino, Elisa
    D'Onofrio, Nunzia
    Anastasio, Camilla
    Abate, Marianna
    Zappavigna, Silvia
    Caraglia, Michele
    Balestrieri, Maria Luisa
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2023, 32 : 371 - 384
  • [2] Nanoparticles for imaging and treatment of metastatic breast cancer
    Mu, Qingxin
    Wang, Hui
    Zhang, Miqin
    EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (01) : 123 - 136
  • [3] Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells
    Mattu, C.
    Pabari, R. M.
    Boffito, M.
    Sartori, S.
    Ciardelli, G.
    Ramtoola, Z.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) : 463 - 472
  • [4] Targeting Engineered Nanoparticles for Breast Cancer Therapy
    Ganesan, Kumar
    Wang, Yan
    Gao, Fei
    Liu, Qingqing
    Zhang, Chen
    Li, Peng
    Zhang, Jinming
    Chen, Jianping
    PHARMACEUTICS, 2021, 13 (11)
  • [5] Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity
    Zheng, Wei
    Wang, Cong
    Ding, Ruihong
    Huang, Yahong
    Li, Yanyi
    Lu, Yan
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 572
  • [6] A Review on Targeting Nanoparticles for Breast Cancer
    Alqaraghuli, Hasanain Gomhor J.
    Kashanian, Soheila
    Rafipour, Ronak
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2019, 20 (13) : 1087 - 1107
  • [7] MicroRNA-34a suppresses breast cancer cell proliferation and invasion by targeting Notch1
    Rui, Xiaoping
    Zhao, Haibin
    Xiao, Xianqiu
    Wang, Li
    Mo, Lin
    Yao, Yao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 4387 - 4392
  • [8] MicroRNA-125a represses cell growth by targeting HuR in breast cancer
    Guo, Xun
    Wu, Yuehan
    Hartley, Rebecca S.
    RNA BIOLOGY, 2009, 6 (05) : 575 - 583
  • [9] 2′-Hydroxyflavanone: A novel strategy for targeting breast cancer
    Singhal, Jyotsana
    Nagaprashantha, Lokesh
    Chikara, Shireen
    Awasthi, Sanjay
    Horne, David
    Singhal, Sharad S.
    ONCOTARGET, 2017, 8 (43) : 75025 - 75037
  • [10] BBN conjugated GNPs: a new targeting contrast agent for imaging of breast cancer in radiology
    Salouti, Mojtaba
    Saghatchi, Faranak
    IET NANOBIOTECHNOLOGY, 2017, 11 (05) : 604 - 611